Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

The shares in DNB Bank ASA will be quoted ex-dividend today

The shares in DNB Bank ASA will be quoted ex-dividend on 26 April 2023. A dividend of NOK 12.50 per share will be distributed on 5 May 2023 to registered shareholders as at 25 April 2023. For further information, please contact:Rune Helland, head of Investor Relations, tel: +47 977 13 250 This information is subject to the disclosure requirements according to Section 5-12 of the Norwegian Securities Trading Act.

Kemppi launches new robotic welding machine

KEMPPI     PRESS RELEASE     26 April 2023   09.00 EET Kemppi launches new robotic welding machine Introducing the Kemppi AX MIG Welder – a powerful robotic welder with seamless integration, an easy-to-use interface, and the latest welding technology.  The AX MIG Welder was purpose-built for high-intensity, 24/7 automated welding environments. With 400 or 500 A power and a robotic wire feeder, it is engineered to perform difficult tasks and meet demanding production targets.  Speed is nothing without quality. The AX MIG Welder has fine-tuned ignition and a precise seam tracking

SAS files monthly operating reports with U.S. court and announces certain financial information for the Group

SAS AB (“SAS” or the “Company”) and each of its subsidiaries that are subject to the voluntary chapter 11 process in the U.S. will shortly file monthly operating reports, containing certain financial information for the period of November 1, 2022 to March 31, 2023 with the U.S. Bankruptcy Court for the Southern District of New York (the “Court”). All SAS companies that are subject to the voluntary chapter 11 process are each required to file operating reports with the Court on a monthly basis. The financial information contained in the monthly operating reports includes items such as cash

Rottneros is investing in renewable energy

The Board of Directors of Rottneros has decided to invest a total of approximately86 MSEK in renewable electricity at Rottneros Mill. The investments include a solar park and a battery storage and are part of a long-term strategy to reduce the groups exposure to the electricity market. The start-up is planned for 2024.The solar park is expected to generate over 3 GWh annually, which can be compared to the company's annual purchased electricity demand of around 220 GWh. The purpose of the battery storage is primarily to contribute to an improved balance on the electricity market, which

Rottneros adds a sustainability link to its long-term financing

Rottneros has supplemented its long-term financing agreement with a sustainability link, which means that the interest rates are linked to some of the environmental and working environment criteria in the group's long-term targets.The sustainability link refers to the loan agreement that Rottneros entered into with Danske Bank in July 2021. It includes a loan of 150 MSEK with 32 MSEK in annual amortization and revolving credits of up to 100 MSEL. The supplement is part of the company's continuous focus on sustainable development. ___________________________________________________________

Invitation – presentation of first-quarter results

KlaraBo will publish its interim report for the first quarter of 2023 at 8:00 a.m. (CEST) on Wednesday, 3 May, and will hold a webcast presentation and conference call at 10:00 a.m. (CEST) the same day. KlaraBo’s CEO Andreas Morfiadakis, CFO Jenny Appenrodt, and Head of Sustainability (interim) Kristin Lundmark will present the interim report and answer questions. The presentation will be held in English. Conference call and webcast presentationTime: 10:00 a.m. (CEST) on Wednesday, 3 May 2023 Link to webcast below. Via the webcast you can ask questions in writing.https://ir.

Rottneros invests for significantly increased production of CTMP

Rottneros’ Board of Directors has decided to invest approximately 180 million SEK to significantly expand the production capacity of CTMP pulp at Rottneros Mill. It will thus increase from today's 125 thousand tonnes to approximately 165 thousand tonnes at a relatively low investment cost. The investment is planned to be operational in 2024.The additional volume of CTMP pulp is primarily intended for the growing market segments of board and packaging as well as tissue. Given the low investment cost per tonne, Rottneros strengthens its long-term competitiveness in the growing CTMP market.

Inify Laboratories - Strong market interest and launch on track

STOCKHOLM – April 26[th], 2023 – Inify Laboratories, a fully integrated digital ultramodern laboratory service that provides cancer diagnostics within pathology, is on track for launch at the end of Q2 this year. “We continue to make good progress with our laboratory. This first quarter has been dominated by work with installation, testing and documentation, to get the laboratory ready to serve public and private clinics with prostate cancer diagnostics,” says CEO Fredrik Palm at Inify Laboratories. The company sees great interest from potential customers, and has received positive

REPORT ON THE FIRST QUARTER 2023

EBITA MARGIN OF 11.6% AND SIGNIFICANTLY IMPROVED OPERATING CASH FLOWFIRST QUARTER 2023 · Net sales were SEK 7,289 m (7,518); a decrease of -3%, of which -13% was organic growth. · Operating profit (EBITA) before items affecting comparability was SEK 847 m (1,114), corresponding to a margin of 11.6% (14.8%). · Items affecting comparability were SEK -26 m (-159). · Operating profit (EBITA) was SEK 821 m (955), corresponding to a margin of 11.3% (12.7%). · Operating profit (EBIT) was SEK 667 m (812), corresponding to a margin of 9.2% (10.8%). · Profit (loss) for the

Hemnet Group Interim report Q1 2023

Summary for the period January-March 2023  · Net sales increased 5.8 percent to SEK 190.1m (179.6) · Adjusted EBITDA increased 2.0 percent to SEK 87.2m  (85.5) · Operating profit increased 0.4 percent to SEK 68.1m (67.8) · ARPL, average revenue per listing, increased 38.2 percent to SEK 3,706 (2,681) · As previously announced, Anders Örnulf will take over as the new CFO. His starting date is now set for 2 May, 2023   +-------------------+-----+-----+---------+------------------+-----+|  |Jan-Mar |Last twelve months|FY |+-----------

Remedy Entertainment Plc's Business Review January-March 2023: Steady progress with Alan Wake 2 towards its 2023 launch

Remedy Entertainment Plc | Stock Exchange Release, April 26, 2023, at 09:00 a.m. (EEST)  Remedy Entertainment Plc | Business Review January–March 2023 Steady progress with Alan Wake 2 towards its 2023 launch     Revenue and profitability affected by the timing of project milestones and investments in ongoing projects The Business Review is unaudited. Figures in parentheses refer to the comparison period in the previous year, unless otherwise stated. HIGHLIGHTS FROM january–March 2023 · Revenue decreased by 45.4% to EUR 6.9 (12.7) million. · EBITDA decreased to EUR -

Rottneros interim report January-March 2023

Stable results in uncertain times· NET SALES increased by 13 percent to 744 (660) MSEK despite the fact that sales of groundwood pulp were limited to remaining inventory from production that ceased in December 2022. Higher sales prices and sustained volume of other products were positive contributing factors.  · THE LIST PRICE for NBSK pulp was 8 percent higher in USD and 21 percent higher in SEK compared to the first quarter of 2022. USD strengthened against the SEK by 12 percent during the same period.  · VOLUME PRODUCED excluding groundwood pulp amounted to 89.6 (86.3) thousand

Q1 2023: Positive one-off effects contributed to growth

Important events during the first quarter · Net sales increased by 11% (2% adjusted for currency effects) to SEK 172 m (155). · The EBITDA margin amounted to 28% (25). · Positive one-off effects totaling SEK 18 m regarding postponed orders from Q4 2022. · Takeover of the distribution of our own brand Probi[®] in Sweden from April 1, 2023. New market organization established. · First commercial batch of spores produced. · Anita Johansen appointed CEO of Probi on March 30. Von Carlson took over as the new VP of Operations on March 27. CEO Comments A strengthened

Notice to attend the Annual General Meeting of Sivers Semiconductors AB (publ)

The shareholders of Sivers Semiconductors AB (publ) (the “Company”), reg. no. 556383-9348, are hereby invited to attend the Annual General Meeting to be held on Thursday, 25 May 2023 at 4.00 pm at the Company’s premises at Torshamnsgatan 48 in Kista, Sweden.Notification to attend etc. Shareholders who wish to attend the Annual General Meeting must · be recorded in the share register kept by Euroclear Sweden AB no later than on Tuesday, 16 May 2023; and  · notify the Company their intention to participate no later than Friday, 19 May 2023, via mail to the address Setterwalls

Stayble Therapeutics announces Dr Daisuke Sakai as new Scientific Advisor

Stayble Therapeutics AB ("Stayble" or the "Company") announces that the Company has strengthened its scientific advisory board with Professor Daisuke Sakai, MD, PhD, as new scientific advisor. Dr Sakai will bring experience from the Japanese perspective in the field of treating degenerative disc disease as well as herniated discs. His broad knowledge in the field will strengthen our current scientific advisory board.Dr Daisuke Sakai is an Associate Professor in the Department of Orthopaedic Surgery at Tokai University School of Medicine in Kanagawa, Japan. Sakai's main clinical interest is

Norse Atlantic ASA – additional information relating to delivery of offer shares, the reverse share split and change of ISIN

Arendal, 26 April 2023: Reference is made to the stock exchange announcement published by Norse Atlantic ASA (the "Company") on 20 April 2023 regarding the successful completion of a subsequent offer of 60,000,000 new shares ("Offer Shares") in the Company (the "Subsequent Offering").  Reference is further made to the stock exchange announcement published by the Company on 21 April 2023 with key information relating to the upcoming reverse share split and change of ISIN.Following registration of the share capital increase pertaining to the issuance of the Offer Shares with the Norwegian

Interim Report 1 January – 31 March 2023

Strong organic growth in both business areas "Strong organic growth of 12 percent in the quarter reflects strong demand for our products and services. We are well-positioned for the recovery that is now taking place in health care and is expected to continue for a long time to come."Fredrik Dalborg, CEO AddLife AddLife´s interim report for Q1 2023 is now available online at the company website. The interim report can be downloaded in pdf version. Visit reports-en.add.life/interim-report-q1-2023 1 JANUARY – 31 MARCH 2023 (3 MONTHS) · Net sales decreased by 5 percent to SEK 2,

Eevia Health Plc receives a 120 KSEK / 11 KEUR sales order for a bilberry extract

Eevia Health Plc, (”Eevia” or ”The Company”), has received a first sales order from a new customer in Germany of c. 11 KEUR for Feno-Myrtillus® 36 Organic, an organically certified bilberry extract.The German customer is new to Eevia. The company is strategically focusing on health effects from Bilberry anthocyanins. The Customer’s end products are supplements with a standardized level of bilberry anthocyanins sold across Germany. The sales value to Eevia of this new order is c. KEUR 11 EUR. The product is Eevia’s branded ingredient Feno-Myrtillus® 36 Organic, which is an organically

Kindred initiates review of strategic alternatives

The Board of Directors of Kindred Group plc initiates a review of strategic alternatives to maximise shareholder value.Kindred Group plc (“Kindred” or the “Company”) has assembled a world-class portfolio of online gaming and sports wagering assets in key jurisdictions around the world, and the Board of Directors is focused on maximizing the value of these assets for the Company’s shareholders. Kindred hereby announces that its Board of Directors has unanimously decided to initiate a process to explore strategic alternatives for the Company. As part of this strategic process, the Board of

Glaston Corporation January─March 2023: Solid performance in the Architectural business continued

GLASTON CORPORATION                  INTERIM REPORT            26.4.2023  AT 8.30This release is a summary of Glaston Corporation's Interim Report for January-March 2023. The complete report is attached to this release as a pdf-file. The release is also available on the company's website at the address www.glaston.net. January─March 2023 in brief · Orders received totaled EUR 56.9 (59.0) million. · Net sales totaled EUR 51.3 (52.3) million. · Comparable EBITA was EUR 3.0 (3.5) million, i.e. 5.8 (6.6)% of net sales. · The operating result (EBIT) was EUR 1.9 (2.2) million.

Interim Report Jan-Mar 2023

Increased rental income, improved net operating income and a lower vacancy rate. Net lettings of SEK 12m were slightly negative but new leases are still being signed at good levels. The yield requirement increased by 0.12 percentage points, which led to unrealised changes in value amounting to SEK -2,110m.· Rental income increased to SEK 829m (762). In an identical property portfolio, income increased with 8 per cent compared with the previous year. · Net operating income increased to SEK 598m (554). In an identical property portfolio, net operating income increased by 8 per cent. ·

Tobii Dynavox Interim report for the first quarter 2023

Tobii Dynavox AB (publ) today announced its results for the first quarter of 2023. Comment by Tobii Dynavox CEO Fredrik Ruben: Sales continue to develop strongly. During the first quarter, which is seasonally our weakest quarter, we report continued good growth across the board, both in North America and in other markets. At the same time, our profitability is moving in the right direction as the negative effects on components and shipping are now behind us. We saw no significant residual COVID-19 effects during the quarter, either positive or negative. As of the second quarter, we

There are no items matching the current filter
There are no more items matching the current filter
Back to top